EP Patent

EP4157231A1 — Hard capsule dosage form and uses thereof

Assigned to Eirgen Pharma Ltd · Expires 2023-04-05 · 3y expired

What this patent protects

Provided herein are hard capsule dosage forms containing a vitamin D compound, and methods of making and using the same.

USPTO Abstract

Provided herein are hard capsule dosage forms containing a vitamin D compound, and methods of making and using the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP4157231A1
Jurisdiction
EP
Classification
—
Expires
2023-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Eirgen Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.